Blood fatty acids in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review

Abdelmagid, 2015, Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults, PLoS One, 10, 10.1371/journal.pone.0116195

Albenberg, 2014, Diet and the intestinal microbiome: associations, functions, and implications for health and disease, Gastroenterology, 146, 1564, 10.1053/j.gastro.2014.01.058

Amminger, 2012, Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals, Mol. Psychiatry, 17, 1150, 10.1038/mp.2011.167

Amtul, 2012, Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer’s disease: structural insight, Neurobiol. Aging, 33, e821

Andrieu, 2017, Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial, Lancet Neurol., 16, 377, 10.1016/S1474-4422(17)30040-6

Association, 1994

Baierle, 2014, Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly, Nutrients, 6, 3624, 10.3390/nu6093624

Baleztena, 2018, Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in &/= 75 years old patients: a randomized multicenter study, PLoS One, 13, 10.1371/journal.pone.0193568

Barbash, 2017, Alzheimer’s brains show inter-related changes in RNA and lipid metabolism, Neurobiol. Dis., 106, 1, 10.1016/j.nbd.2017.06.008

Barreto, 2018, Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial, Age Ageing, 47, 281, 10.1093/ageing/afx164

Bazan, 2007, Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection, Curr. Opin. Clin. Nutr. Metab. Care, 10, 136, 10.1097/MCO.0b013e32802b7030

Bekkering, 2013, The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes, Expert Rev. Clin. Immunol., 9, 1031, 10.1586/1744666X.2013.848793

Bersch-Ferreira, 2018, Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study, Nutr. J., 17, 26, 10.1186/s12937-018-0342-1

Borjesson, 2010, Electrostatic tuning of cellular excitability, Biophys. J., 98, 396, 10.1016/j.bpj.2009.10.026

Bosman, 1992, Are thrombocyte membranes altered in Alzheimer’s disease? A morphometric and biochemical study, Neurobiol. Aging, 13, 711, 10.1016/0197-4580(92)90094-E

Calder, 2006, n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases, Am. J. Clin. Nutr., 83, 1505S, 10.1093/ajcn/83.6.1505S

Cani, 2018, Human gut microbiome: hopes, threats and promises, Gut, 67, 1716, 10.1136/gutjnl-2018-316723

Carabotti, 2015, The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems, Ann. Gastroenterol., 28, 203

Cherubini, 2007, Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study, J. Gerontol. A Biol. Sci. Med. Sci., 62, 1120, 10.1093/gerona/62.10.1120

Chhetri, 2018, Effects of a 3-Year multi-domain intervention with or without Omega-3 supplementation on cognitive functions in older subjects with increased CAIDE dementia scores, J. Alzheimers Dis., 64, 71, 10.3233/JAD-180209

Conquer, 2000, Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment, Lipids, 35, 1305, 10.1007/s11745-000-0646-3

Contreras, 2014, Myristic acid produces anxiolytic-like effects in Wistar rats in the elevated plus maze, Biomed Res. Int., 2014, 492141, 10.1155/2014/492141

Corrigan, 1991, Tin and fatty acids in dementia, Prostaglandins Leukot. Essent. Fatty Acids, 43, 229, 10.1016/0952-3278(91)90035-4

Cui, 2015, Gas chromatography-mass spectrometry analysis of the free fatty acids in serum obtained from patients with Alzheimer’s disease, Biomed. Mater. Eng., 26, S2165

Cunnane, 2007, Linking low docosahexaenoic acid intake to Alzheimer’s disease: caution recommended, Corps gras, Lipides, 14, 177, 10.1051/ocl.2007.0118

Cunnane, 2012, Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis., 29, 691, 10.3233/JAD-2012-110629

D’Ascoli, 2016, Association between serum long-chain omega-3 polyunsaturated fatty acids and cognitive performance in elderly men and women: the Kuopio Ischaemic Heart Disease Risk Factor Study, Eur. J. Clin. Nutr., 70, 970, 10.1038/ejcn.2016.59

Dinan, 2017, Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration, J. Physiol. (Paris), 595, 489

Fang, 2017, Targeted metabolomics reveals altered oxylipin profiles in plasma of mild cognitive impairment patients, Metabolomics, 13, 10.1007/s11306-017-1249-0

Fernandez-Real, 2005, Circulating adiponectin and plasma fatty acid profile, Clin. Chem., 51, 603, 10.1373/clinchem.2004.041350

Fonteh, 2014, Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer’s disease, PLoS One, 9, 10.1371/journal.pone.0100519

Fraser, 1999, Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation, Rheumatology Oxford (Oxford), 38, 948, 10.1093/rheumatology/38.10.948

Gong, 2011, Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine?, Am. J. Clin. Nutr., 93, 186, 10.3945/ajcn.110.006502

Guan, 1999, Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease, J. Neuropathol. Exp. Neurol., 58, 740, 10.1097/00005072-199907000-00008

Han, 2001, Plasmalogen deficiency in early Alzheimer’s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry, J. Neurochem., 77, 1168, 10.1046/j.1471-4159.2001.00332.x

Han, 2011, Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics, PLoS One, 6, 10.1371/journal.pone.0021643

He, 2010, Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease, Nature, 467, 95, 10.1038/nature09325

Hellstrom-Lindahl, 2008, Age-dependent decline of neprilysin in Alzheimer’s disease and normal brain: inverse correlation with A beta levels, Neurobiol. Aging, 29, 210, 10.1016/j.neurobiolaging.2006.10.010

Hooper, 2017, Cross-sectional associations of total plasma homocysteine with cortical beta-amyloid independently and as a function of omega 3 polyunsaturated fatty acid status in older adults at risk of dementia, J. Nutr. Health Aging, 21, 1075, 10.1007/s12603-017-0989-x

Hu, 2016, Alzheimer’s disease and gut microbiota, Sci. China Life Sci., 59, 1006, 10.1007/s11427-016-5083-9

Hussain, 2019, Lipids as biomarkers of brain disorders, Crit Rev Food Sci Nutr1-24.

Ichi, 2014, Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency, Biochim. Biophys. Acta, 1841, 204, 10.1016/j.bbalip.2013.10.013

Igarashi, 2007, Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation, J. Lipid Res., 48, 1150, 10.1194/jlr.M600549-JLR200

Iuliano, 2013, Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis., 36, 545, 10.3233/JAD-122224

Jackson, 2018, Fish oil supplementation does not affect cognitive outcomes in cardiac surgery patients in the Omega-3 fatty acids for prevention of post-operative atrial fibrillation (OPERA) trial, J. Nutr., 148, 472, 10.1093/jn/nxx002

Jerneren, 2015, Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial, Am. J. Clin. Nutr., 102, 215, 10.3945/ajcn.114.103283

Kalmijn, 1997, Dietary fat intake and the risk of incident dementia in the Rotterdam Study, Ann. Neurol., 42, 776, 10.1002/ana.410420514

Karimi, 2017, DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study, Am. J. Clin. Nutr., 106, 1157, 10.3945/ajcn.117.155648

La Rosa, 2018, The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials, Nutrients, 10, 10.3390/nu10091267

Laurin, 2003, Omega-3 fatty acids and risk of cognitive impairment and dementia, J. Alzheimers Dis., 5, 315, 10.3233/JAD-2003-5407

Lauritzen, 2016, DHA effects in brain development and function, Nutrients, 8, 10.3390/nu8010006

Liu, 2012, Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids, Anaerobe, 18, 331, 10.1016/j.anaerobe.2012.02.004

Martinez, 1998, Fatty acid composition of human brain phospholipids during normal development, J. Neurochem., 71, 2528, 10.1046/j.1471-4159.1998.71062528.x

McInnes, 2018, Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement, JAMA, 319, 388, 10.1001/jama.2017.19163

McKhann, 1984, Clinical diagnosis of alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer’s disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

McNamara, 2010, Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study, Am. J. Clin. Nutr., 91, 1060, 10.3945/ajcn.2009.28549

McNamara, 2018, Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment, Neurobiol. Aging, 64, 147, 10.1016/j.neurobiolaging.2017.12.003

Menni, 2017, Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women, Sci. Rep., 7, 11079, 10.1038/s41598-017-10382-2

Mielke, 2010, Alterations of the sphingolipid pathway in Alzheimer’s disease: new biomarkers and treatment targets?, Neuromolecular Med., 12, 331, 10.1007/s12017-010-8121-y

Mitchell, 2011, Fatty acid transport into the brain: of fatty acid fables and lipid tails, Prostaglandins Leukot. Essent. Fatty Acids, 85, 293, 10.1016/j.plefa.2011.04.007

Mitchell, 2011, Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells, J. Neurochem., 117, 735

Moore, 1991, Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6), J. Neurochem., 56, 518, 10.1111/j.1471-4159.1991.tb08180.x

Morris, 2003, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch. Neurol., 60, 940, 10.1001/archneur.60.7.940

Mulder, 1998, Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4, Alzheimer Dis. Assoc. Disord., 12, 198, 10.1097/00002093-199809000-00012

Neth, 2017, Insulin resistance and alzheimer’s disease: bioenergetic linkages, Front. Aging Neurosci., 9, 345, 10.3389/fnagi.2017.00345

Nolan, 2018, Nutritional intervention to prevent alzheimer’s disease: potential benefits of xanthophyll carotenoids and Omega-3 fatty acids combined, J. Alzheimers Dis., 64, 367, 10.3233/JAD-180160

Odutuga, 1977, Recovery of brain from deficiency of essential fatty acids in rats, Biochim. Biophys. Acta, 487, 1, 10.1016/0005-2760(77)90038-8

Odutuga, 1979, Long-term deficiency of essential fatty acids in rats and its effect on brain recovery, Clin. Exp. Pharmacol. Physiol., 6, 361, 10.1111/j.1440-1681.1979.tb00022.x

Ogawa, 1996, Altered energy metabolism in Alzheimer’s disease, J. Neurol. Sci., 139, 78, 10.1016/0022-510X(96)00033-0

Olde Rikkert, 2014, Differences in nutritional status between very mild Alzheimer’s disease patients and healthy controls, J. Alzheimers Dis., 41, 261, 10.3233/JAD-131892

Oresic, 2018, Targeted serum metabolite profiling identifies metabolic signatures in patients with alzheimer’s disease, normal pressure hydrocephalus and brain tumor, Front. Neurosci., 11, 747, 10.3389/fnins.2017.00747

Oulhaj, 2016, Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment, J. Alzheimers Dis., 50, 547, 10.3233/JAD-150777

Panda, 2014, Short-term effect of antibiotics on human gut microbiota, PLoS One, 9, 10.1371/journal.pone.0095476

Patel, 2008, Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity, J. Pharmacol. Exp. Ther., 325, 698, 10.1124/jpet.107.134908

Petersen, 2004, Mild cognitive impairment as a diagnostic entity, J. Intern. Med., 256, 183, 10.1111/j.1365-2796.2004.01388.x

Petersen, 1999, Mild cognitive impairment: clinical characterization and outcome, Arch. Neurol., 56, 303, 10.1001/archneur.56.3.303

Prasad, 1998, Regional membrane phospholipid alterations in Alzheimer’s disease, Neurochem. Res., 23, 81, 10.1023/A:1022457605436

Purdon, 1997, No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat, J. Lipid Res., 38, 526, 10.1016/S0022-2275(20)37260-6

Qin, 2003, Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity, J. Biol. Chem., 278, 50970, 10.1074/jbc.M307699200

Ramirez-Ramirez, 2013, Efficacy of fish oil on serum of TNF alpha, IL-1 beta, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b, Oxid. Med. Cell. Longev., 2013, 709493, 10.1155/2013/709493

Rudman, 1989, Serum fatty acid profile of elderly tube-fed men in a nursing home, J. Am. Geriatr. Soc., 37, 229, 10.1111/j.1532-5415.1989.tb06812.x

Schippling, 2000, Increased lipoprotein oxidation in Alzheimer’s disease, Free Radic. Biol. Med., 28, 351, 10.1016/S0891-5849(99)00247-6

Schwarz, 2018, Effects of Omega-3 fatty acids on resting cerebral perfusion in patients with mild cognitive impairment: a randomized controlled trial, J. Prev. Alzheimers Dis., 5, 26

Selley, 2007, A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer’s disease, Neurobiol. Aging, 28, 1834, 10.1016/j.neurobiolaging.2006.08.003

Shang, 2018, Different associations of plasma biomarkers in alzheimer’s disease, mild cognitive impairment, vascular dementia, and ischemic stroke, J. Clin. Neurol., 14, 29, 10.3988/jcn.2018.14.1.29

Siguel, 1987, Criteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid chromatography, Clin. Chem., 33, 1869, 10.1093/clinchem/33.10.1869

Snowden, 2017, Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study, PLoS Med., 14, 10.1371/journal.pmed.1002266

Soininen, 2017, 24-month intervention with a specific multinutrient in people with prodromal Alzheimer’s disease (LipiDiDiet): a randomised, double-blind, controlled trial, Lancet Neurol., 16, 965, 10.1016/S1474-4422(17)30332-0

Solfrizzi, 2009, Dietary fatty acids and predementia syndromes, Scien.World J., 9, 792, 10.1100/tsw.2009.82

Spector, 1988, Fatty acid transport through the blood-brain barrier, J. Neurochem., 50, 639, 10.1111/j.1471-4159.1988.tb02958.x

Srinivasan, 1989, Inhibitors of the arachidonic acid cascade in the management of ocular inflammation, Prog. Clin. Biol. Res., 312, 229

Swanson, 2012, Omega-3 fatty acids EPA and DHA: health benefits throughout life, Adv. Nutr., 3, 1, 10.3945/an.111.000893

Tabue-Teguo, 2018, Effect of multidomain intervention, Omega-3 polyunsaturated fatty acids supplementation or their combinaison on cognitive function in non-demented older adults according to frail status: results from the MAPT study, J. Nutr. Health Aging, 22, 923, 10.1007/s12603-018-1024-6

Thomas, 2017, Dietary arachidonic acid increases deleterious effects of amyloid-beta oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance, Alzheimers Res. Ther., 9, 69, 10.1186/s13195-017-0295-1

Tokuda, 2014, Arachidonic acid-enriched triacylglycerol improves cognitive function in elderly with low serum levels of arachidonic acid, J. Oleo Sci., 63, 219, 10.5650/jos.ess13195

Tokuda, 2014, Differential effect of arachidonic acid and docosahexaenoic acid on age-related decreases in hippocampal neurogenesis, Neurosci. Res., 88, 58, 10.1016/j.neures.2014.08.002

Vedin, 2008, Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study, Am. J. Clin. Nutr., 87, 1616, 10.1093/ajcn/87.6.1616

Wang, 2012, Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer’s disease, Neurobiol. Aging, 33, 1057, 10.1016/j.neurobiolaging.2010.09.013

Watson, 2003, The role of insulin resistance in the pathogenesis of Alzheimer’s disease: implications for treatment, CNS Drugs, 17, 27, 10.2165/00023210-200317010-00003

Wiktorowska-Owczarek, 2015, PUFAs: structures, metabolism and functions, Adv. Clin. Exp. Med., 24, 931, 10.17219/acem/31243

Wilson, 1997, Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer’s disease, Am. J. Pathol., 150, 2181

Yamazaki, 2014, Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome, J. Oleo Sci., 63, 527, 10.5650/jos.ess13226

Yin, 2015, Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: a cross-sectional study, J. Nutr. Health Aging, 19, 39, 10.1007/s12603-014-0510-8

Youdim, 2000, Essential fatty acids and the brain: possible health implications, Int. J. Dev. Neurosci., 18, 383, 10.1016/S0736-5748(00)00013-7

Zhang, 2018, DHA supplementation improves cognitive function via enhancing Abeta-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial, J Neurol Neurosurg Psychiatry, 89, 382, 10.1136/jnnp-2017-316176